Patología Hepática 12.- EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic S 50 fatty liver disease. J Hepatol 2016; 64: 1388-402. 13.- Loguercio C, De Simone T, Federico A, Terracciano F, Di Chicco M, et al. Gutliver axis: a new point of attack to treat Micr obi ota e h ígad o gra so - G. Araneda M. et al. chronic liver damage. Am J Gastroenterol 2002; 97: 2144-6. 14.- Gao X, Zhu Y, Wen Y, Liu G, Wan C. Efficacy of probiotics in nonalcoholic fatty liver disease in adult and children: a meta-analysis of randomized controlled trials. Hepatol Res 2016 Publicación electrónica en avance. Disponible en: http://dx.doi.org/10.1111/hepr.12671. 15.- Ma Y, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: a metaanalysis. World J Gastroenterol 2013; 19: 6911-8. Gastroenterol. latinoam 2016; Vol 27, S upl Nº 1: S 47-S 50
Gastro_3
To see the actual publication please follow the link above